GLP-1 medications have transformed the weight loss landscape GLP-1 medications such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have transformed the weight loss landscape
10.1186/s12889-023-14994-4 76 LoeppkyJ
All content of this page is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider
Since liraglutide is not metabolized or eliminated by the kidneys or liver, its pharmacokinetics are not significantly affected by renal or hepatic dysfunction, providing a potential treatment advantage in patients with type 2 diabetes and concomitant kidney/liver disease [59]
[DOI] [PubMed] [Google Scholar] 39.Morris D, Khurasany M, Nguyen T, Kim J, Guilford F, Mehta R et al
Plasma half-life measures how long the peptide remains detectable in circulation 26120 minutes for ipamorelin and 2638 minutes for tesamorelin